| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 133 | 142 | 143 | 143 | 156 | 170 | 176 | 178 | 186 | 194 | 219 | 212 | 229 | 228 | 248 | 250 | 261 | 270 | 279 | 279 | 271 | 195 | 251 | 279 | 302 | 326 | 495 | 360 | 367 | 410 | 421 | 428 | 446 | 463 | 489 | 475 | 502 | 534 | 564 | 563 | 594 |
| Expenses | 115 | 123 | 127 | 125 | 131 | 144 | 149 | 150 | 153 | 162 | 180 | 180 | 191 | 198 | 213 | 222 | 231 | 228 | 238 | 234 | 236 | 176 | 218 | 245 | 343 | 272 | 292 | 342 | 302 | 336 | 345 | 349 | 365 | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 |
| EBITDA | 19 | 19 | 17 | 18 | 25 | 26 | 28 | 28 | 34 | 32 | 39 | 32 | 38 | 30 | 34 | 28 | 30 | 43 | 42 | 45 | 35 | 19 | 33 | 34 | -41 | 55 | 202 | 18 | 65 | 74 | 76 | 78 | 80 | 76 | 87 | 84 | 100 | 99 | 112 | 93 | 114 |
| Operating Profit % | 13 % | 13 % | 11 % | 12 % | 15 % | 14 % | 15 % | 15 % | 16 % | 15 % | 15 % | 13 % | 14 % | 13 % | 13 % | 11 % | 10 % | 15 % | 14 % | 15 % | 12 % | 8 % | 12 % | 10 % | -16 % | 16 % | 17 % | 4 % | 17 % | 18 % | 18 % | 18 % | 17 % | 16 % | 17 % | 17 % | 18 % | 17 % | 18 % | 16 % | 18 % |
| Depreciation | 10 | 11 | 11 | 11 | 12 | 13 | 14 | 15 | 15 | 15 | 17 | 18 | 21 | 20 | 21 | 22 | 23 | 34 | 35 | 38 | 42 | 39 | 40 | 42 | 38 | 38 | 38 | 41 | 41 | 40 | 41 | 41 | 42 | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 |
| Interest | 9 | 9 | 9 | 10 | 11 | 5 | 6 | 5 | 7 | 7 | 10 | 10 | 15 | 18 | 24 | 13 | 16 | 31 | 35 | 36 | 36 | 37 | 27 | 29 | 26 | 26 | 23 | 24 | 24 | 25 | 26 | 27 | 26 | 26 | 27 | 30 | 27 | 34 | 36 | 41 | 44 |
| Profit Before Tax | 0 | 0 | -1 | -1 | 2 | 8 | 8 | 8 | 12 | 10 | 12 | 4 | 2 | -8 | -10 | -7 | -8 | -23 | -27 | -28 | -42 | -57 | -32 | -35 | -104 | -9 | 142 | -46 | 1 | 10 | 10 | 11 | 13 | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 |
| Tax | 0 | -0 | -1 | 1 | -2 | 3 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | -1 | -3 | -1 | 3 | -2 | -2 | 1 | 9 | -11 | -5 | -1 | 9 | 4 | 43 | 4 | -1 | 8 | 5 | 7 | 8 | 7 | 7 | 8 | 5 | 5 | 7 | -11 | 7 |
| Net Profit | 0 | 1 | -1 | -2 | 4 | 5 | 5 | 5 | 8 | 6 | 10 | 1 | -0 | -6 | -8 | -6 | -11 | -21 | -25 | -29 | -50 | -46 | -27 | -35 | -114 | -13 | 99 | -50 | 2 | 3 | 5 | 4 | 6 | 4 | 11 | 3 | 24 | 14 | 21 | 8 | 7 |
| EPS in ₹ | -0.04 | -0.07 | -0.23 | -0.30 | 0.44 | 0.59 | 0.58 | 0.63 | 0.90 | 0.55 | 1.17 | 0.37 | 0.30 | -0.39 | -0.74 | -0.71 | -0.99 | -2.05 | -2.51 | -2.57 | -4.91 | -4.48 | -1.94 | -2.33 | -8.14 | -0.76 | 8.22 | -3.55 | 0.43 | 0.44 | 0.53 | 0.54 | 0.60 | 0.55 | 0.97 | 0.41 | 1.53 | 0.87 | 1.29 | 0.50 | 0.53 |
Healthcare Global Enterprises
539.40
-11.50
(-2.09%)
Q4 Quarterly Results are out. Check out the updated financials2 days ago
View
Market Cap
7,680.40 Cr
EPS
3.46
PE Ratio
172.34
Dividend Yield
0.00 %
Industry
Healthcare Services52 Week High
639.00
52 Week Low
330.65
PB Ratio
8.31
Debt to Equity
1.29
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
Company News
View All News
Healthcare Global Enterprises Ltd Reports Q4 Financial Results3 days ago
Healthcare Global Enterprises Ltd has announced its quarterly financial results. The company reported a consolidated net profit of 67 million rupees, compared to 234 million rupees in the same quarter last year and 77 million rupees in the previous quarter. Revenue for the quarter stood at 5.83 billion rupees, up from 4.93 billion rupees year-over-year and 5.57 billion rupees quarter-over-quarter.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,135.20 | #1 1,10,357.57 | 98.86 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 51.53 | |
6,923.00 | 99,542.12 | 76.28 | #1 19,165.50 | 14.74 | 917 | 49.14 | 50.68 | |
716.30 | 54,077.65 | 63.40 | 6,931.20 | 8.99 | 645 | -7.43 | 58.47 | |
1,764.80 | 36,065.59 | #1 44.21 | 5,093.40 | 10.96 | 790 | 3.41 | 45.69 | |
1,197.10 | 32,152.60 | 62.62 | 2,759.20 | #1 25.09 | 326 | -20.35 | 49.96 | |
541.00 | 27,023.66 | 73.01 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 52.05 | |
649.15 | 26,083.10 | 69.19 | 2,511.20 | 12.94 | 336 | 48.39 | 51.21 | |
1,399.30 | 14,210.13 | 58.71 | 1,334.00 | 10.76 | 218 | 10.57 | 57.52 | |
1,443.80 | 9,486.70 | 49.01 | 1,095.50 | 21.32 | 177 | -0.88 | 49.82 | |
539.40 | #10 7,680.40 | #10 172.34 | #8 1,929.10 | #6 12.97 | #10 41 | #10 -71.06 | 44.42 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
12.97 %
Net Income Growth
134.66 %
Cash Flow Change
13.11 %
ROE
135.47 %
ROCE
5.76 %
EBITDA Margin (Avg.)
-1.64 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 |
| Fixed Assets | 529 | 568 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 |
| Current Assets | 122 | 201 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 680 |
| Capital Work in Progress | 42 | 155 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 |
| Investments | 0 | 60 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 |
| Other Assets | 205 | 252 | 382 | 389 | 482 | 527 | 597 | 642 | 735 | 856 |
| Total Liabilities | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 |
| Current Liabilities | 187 | 195 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 744 |
| Non Current Liabilities | 284 | 270 | 371 | 506 | 584 | 1,258 | 856 | 866 | 876 | 1,099 |
| Total Equity | 305 | 569 | 490 | 579 | 522 | 420 | 714 | 884 | 869 | 865 |
| Reserve & Surplus | 209 | 451 | 347 | 398 | 389 | 293 | 528 | 731 | 721 | 687 |
| Share Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 3 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 |
| Investing Activities | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 |
| Operating Activities | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | 285 |
| Financing Activities | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 70.71 % | 68.41 % | 68.40 % | 71.44 % | 71.43 % | 71.42 % | 71.39 % | 71.38 % | 71.37 % | 71.35 % | 71.30 % | 71.29 % | 71.28 % | 71.25 % | 71.23 % | 71.23 % | 71.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.28 % | 0.00 % | 6.74 % | 3.95 % | 4.29 % | 2.77 % | 2.45 % |
| DIIs | 7.82 % | 7.86 % | 6.27 % | 5.52 % | 4.90 % | 3.56 % | 4.03 % | 4.40 % | 5.54 % | 6.58 % | 7.94 % | 6.66 % | 8.52 % | 10.89 % | 11.64 % | 12.94 % | 12.47 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.05 % | 9.46 % | 10.83 % | 10.07 % | 10.84 % | 11.58 % | 11.21 % | 11.60 % | 11.44 % | 10.43 % | 9.96 % | 9.68 % | 9.39 % | 9.41 % | 9.33 % | 9.60 % | 10.43 % |
| Others | 14.42 % | 14.26 % | 14.50 % | 12.97 % | 12.83 % | 13.44 % | 13.38 % | 12.61 % | 11.65 % | 11.63 % | 4.52 % | 12.37 % | 4.07 % | 4.49 % | 3.50 % | 3.46 % | 3.43 % |
| No of Share Holders | 13,891 | 15,065 | 20,573 | 22,362 | 23,663 | 23,018 | 24,672 | 28,707 | 28,858 | 25,931 | 27,327 | 27,289 | 27,195 | 26,529 | 29,670 | 32,820 | 45,394 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 May 2025 |  Quarterly Result Announcement | NA | 24 May 2025 | 550.30 | 594.65 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 531.05 | 510.60 |
| 09 Nov 2024 | Quarterly Result Announcement | NA | 09 Nov 2024 | 423.60 | 468.10 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 399.45 | 421.10 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance
2 days ago
2 days agoEarnings Call Held With Analysts/Investors To Discuss The Audited Financial Results Of The Quarter And Year Ended March 31 20253 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 20154 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation4 days ago
4 days agoIntegrated Filing (Financial)4 days ago
4 days agoBoard Meeting Outcome for Annual Financial Results (Standalone And Consolidated) For Quarter And Year Ended March 31 20254 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2025
May 12, 2025Board Meeting Intimation for Considering Approving And Taking On Record The Audited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2025 (Audited Financial Results).May 12, 2025
May 12, 2025Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
May 08, 2025Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 02, 2025
May 02, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2025
Apr 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Apr 17, 2025Announcement Under Regulation 30Apr 16, 2025
Apr 16, 2025Clarification sought from HealthCare Global Enterprises LtdApr 16, 2025
Apr 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Cautionary E-Mail From BSE Limited Dated March 28 2025Mar 28, 2025
Mar 28, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 28, 2025
Mar 28, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 19, 2025
Mar 19, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Mar 19, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 11, 2025
Mar 11, 2025Draft Letter of OfferMar 11, 2025
Mar 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMar 06, 2025
Mar 06, 2025Announcement Under Regulation 30 Of SEBI (LODR) RegulationsMar 03, 2025
Mar 03, 2025Detailed Public StatementMar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 27, 2025
Feb 27, 2025Disclosure under Regulation 30A of LODRFeb 25, 2025
Feb 25, 2025Integrated Filing (Financial)Feb 24, 2025
Feb 24, 2025Public Announcement - Open OfferFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Feb 23, 2025Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 23, 2025
Feb 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 23, 2025
Feb 23, 2025Announcement Under Regulation 30Feb 23, 2025
Feb 23, 2025Announcement Under Regulation 30Feb 23, 2025
Feb 23, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Feb 23, 2025Board Meeting Outcome for Disclosure Under Regulation 30Feb 23, 2025
Feb 23, 2025Announcment Under Regulation 30- Rescheduling Of Earnings CallFeb 19, 2025
Feb 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 16, 2025
Feb 16, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 16, 2025
Feb 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 14, 2025
Feb 14, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Feb 14, 2025Results- Financial Results For Decembe 31 2024Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 11, 2025
Feb 11, 2025Technical Indicators
RSI(14)
Neutral 44.42
ATR(14)
Less Volatile 26.37
STOCH(9,6)
Neutral 32.23
STOCH RSI(14)
Oversold 5.93
MACD(12,26)
Bearish -7.24
ADX(14)
Weak Trend 20.07
UO(9)
Bearish 38.23
ROC(12)
Downtrend And Accelerating -4.27
WillR(14)
Neutral -78.03
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Samco Multi Cap Fund Direct-Growth | 0 | 0.00% | -0.57% | -0.54% | Apr 2025 | |
 Motilal Oswal Multi Cap Fund Direct - Growth | 2580559 | 4.19% | 0.27% | -0.74% | Apr 2025 | |
| Motilal Oswal Business Cycle Fund Direct-Growth | 1750000 | 5.64% | 0.22% | 0.16% | Apr 2025 | |
 ITI Pharma and Healthcare Fund Direct - Growth | 63013 | 1.62% | -0.10% | -0.08% | Apr 2025 | |
| Samco Special Opportunities Fund Direct - Growth | 97063 | 3.65% | 0.09% | 0.14% | Apr 2025 | |
 Tata Small Cap Fund Direct - Growth | 3347532 | 2.00% | 0.03% | -0.03% | Apr 2025 | |
| Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 117843 | 0.33% | 0.01% | -0.01% | Apr 2025 | |
| Tata India Pharma & Healthcare Fund Direct-Growth | 666121 | 3.06% | 0.01% | 0.49% | Apr 2025 | |
| Tata Focused Equity Fund Direct - Growth | 758709 | 2.42% | 0.01% | 0.09% | Apr 2025 | |
 Nippon India ELSS Tax Saver Fund Direct-Growth | 3500000 | 1.33% | 0.01% | 0.02% | Apr 2025 | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 83 | 0.01% | 0.00% | 0.00% | Apr 2025 | |
 Sundaram Long Term Tax Advantage Fund Series II Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Nippon India Pharma Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| ICICI Prudential Exports and Services Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 71 | 0.01% | 0.00% | 0.01% | Apr 2025 | |
| Sundaram Long Term Tax Advantage Fund Series III Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
 Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Tata Equity Savings Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
 Groww Nifty Total Market Index Fund Direct - Growth | 599 | 0.01% | 0.00% | 0.00% | Apr 2025 | |
 Bandhan Nifty Total Market Index Fund Direct-Growth | 81 | 0.01% | 0.00% | 0.00% | Apr 2025 |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
